Filing Details
- Accession Number:
- 0000950170-24-103683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-04 21:11:49
- Reporting Period:
- 2024-09-03
- Accepted Time:
- 2024-09-04 21:11:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1589641 | A Stuart Tross | 1 Casper Street Danbury CT 06810 | Chief People & Workpl Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Disposition | 2024-09-03 | 25,000 | $6.26 | 1,022,191 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction occurred pursuant to Rule 10b5-1 Plan established May 31, 2024.
- The weighted average sales price of the reported transaction was $6.26 based on a range of prices between $6.19 and $6.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.